---
schema_version: "secwatch.filing_event.v1"
accession: "0001601485-23-000065"
form_type: "8-K"
ticker: "ELTX"
cik: "0001601485"
company_name: "Elicio Therapeutics, Inc."
filed_at: "2023-10-20T23:59:59+00:00"
generated_at: "2026-06-09T18:35:10.216292+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Elicio Therapeutics announces departure of Chief Business Officer Annette Matthies effective Oct 19, 2023

## Summary
- Annette Matthies, Ph.D. ceased as Chief Business Officer; separation agreement signed October 19, 2023.
- Company will pay six months of base salary and reimburse COBRA premiums for up to six months.
- Separation includes standard release of claims and confidentiality covenants.
- No replacement or successor has been named; reason for departure not disclosed.

## SEC filing metadata
- accession: 0001601485-23-000065
- form_type: 8-K
- ticker: ELTX
- cik: 0001601485
- company_name: Elicio Therapeutics, Inc.
- filed_at: 2023-10-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601485/000160148523000065/0001601485-23-000065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601485/000160148523000065/angn-20231019.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601485-23-000065
- JSON: https://secwatch.observer/filing/0001601485-23-000065.json
- Plain text: https://secwatch.observer/filing/0001601485-23-000065.txt

## Key facts
- Executive change
  Annette Matthies departed as Chief Business Officer at Elicio Therapeutics, Inc..
  - Action: ceased
  - Role: Chief Business Officer
  source text: On October 19, 2023 , Elicio Therapeutics, Inc. (the “Company”) and Annette Matthies, Ph.D., former Chief Business Officer of the Company, entered into a Separation and Release Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/1601485/000160148523000065/0001601485-23-000065-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.